Can Iron Deficiency Anemia Cause Elevated TSH with Normal T4?
Yes, iron deficiency anemia can cause elevated TSH levels while T4 remains normal, creating a picture that mimics subclinical hypothyroidism. This is a well-documented association supported by multiple recent studies, and it's a critical diagnostic pitfall that clinicians must recognize 1, 2.
The Mechanism and Evidence
Iron deficiency impairs thyroid hormone synthesis because iron is essential for thyroid peroxidase enzyme activity, which is required for iodine oxidation during thyroid hormone production. This biochemical relationship translates into measurable clinical effects:
Recent population studies confirm the association: A 2026 Jordanian study of 3,605 adults found that individuals with iron deficiency anemia had significantly higher TSH levels and lower FT3 and FT4 levels compared to controls, with a higher prevalence of both overt and subclinical hypothyroidism 1.
The hemoglobin correlation is stronger than ferritin: A 2025 meta-analysis of 53,152 pregnant women demonstrated that hemoglobin levels were inversely associated with TSH (p=0.009) and directly associated with free T4 (p<0.001), while serum ferritin showed no significant associations 3. This suggests hemoglobin may be a more reliable marker for detecting this relationship.
Clinical prevalence is substantial: A 2025 Saudi Arabian study of 8,542 pregnant women found that 76.6% had iron deficiency, and both low ferritin and low hemoglobin were significantly associated with elevated TSH levels (p=0.001 and p=0.034, respectively) 2.
Clinical Implications and Diagnostic Approach
Before diagnosing true subclinical hypothyroidism, you must exclude iron deficiency as a contributing factor. The 2004 JAMA guidelines on subclinical hypothyroidism emphasize that other causes of elevated TSH must be excluded before making this diagnosis 4.
Key diagnostic steps:
- Check complete iron studies (ferritin, hemoglobin, serum iron, TIBC) in any patient presenting with elevated TSH and normal T4
- Consider that the TSH elevation may be reversible with iron repletion alone
- Be aware that 86% of patients with iron deficiency anemia may have concurrent subclinical hypothyroidism 5
Treatment Considerations
When both conditions coexist, treating the subclinical hypothyroidism improves the response to iron therapy. A 2009 randomized controlled trial demonstrated that patients receiving both levothyroxine and iron had significantly greater increases in hemoglobin (1.9 g/dL vs 0.4 g/dL, p<0.0001) compared to iron alone 6. This bidirectional relationship means:
- Iron deficiency can elevate TSH
- Subclinical hypothyroidism impairs response to oral iron therapy
- Combined treatment yields superior hematologic outcomes
Critical pitfall to avoid:
Iron supplementation can interfere with levothyroxine absorption even with appropriate dose separation. A 2026 case report documented persistent severe hypothyroidism (TSH >100 mU/L) despite 250 µg daily levothyroxine and a 4-hour separation from iron supplementation 7. The patient only normalized after switching to intravenous iron. This means standard dose separation recommendations may be insufficient in some patients.
Practical Algorithm
- Patient presents with elevated TSH and normal T4
- Check iron studies (ferritin, hemoglobin, serum iron, TIBC)
- If iron deficiency is present:
- Consider this as a contributing factor to TSH elevation
- Replete iron stores (preferably IV iron if also starting levothyroxine to avoid absorption interference)
- Recheck TSH after iron repletion (typically 6-8 weeks)
- If TSH remains elevated after iron correction:
- Diagnose true subclinical hypothyroidism
- Initiate levothyroxine per standard guidelines
- If both conditions require treatment simultaneously:
The relationship between iron deficiency and thyroid function is bidirectional and clinically significant, affecting both diagnosis and treatment efficacy.